{"transactions":[{"id":3547585,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":158106,"kind":"person","name":"Kelley Lynne E","position":1,"cik":"0001667584","reported_name":"Kelley Lynne E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-04-26T19:58:35.000Z","date":"2019-04-24","kind":"grant","acquired":true,"shares":37170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on April 24, 2020, with the remainder vesting in equal installments of 2.083% of the shares subject to the option on the last day of each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":37170,"derivative":{"exercise_price":20.3,"expiration_date":"2029-04-24","underlying":"Common Stock","underlying_shares":37170},"source":{"system":"sec-edgar","filing":"0000899243-19-011289","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667584/000089924319011289/doc4.xml","form_type":"4"}},{"id":3798805,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":158106,"kind":"person","name":"Kelley Lynne E","position":1,"cik":"0001667584","reported_name":"Kelley Lynne E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-03T17:03:52.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") that became effective on October 1, 2018. Pursuant to the Option Repricing, the exercise price of each \"Relevant Option\" (any stock option awarded by the Issuer under it 2012 Equity Incentive Plan or 2013 Equity Incentive Plan with an exercise price greater than $ 0.75628 per share held by current service providers other than the non-employee members of the Issuer's board of directors) has been amended to reduce such exercise price to $0.568, which was the closing price of a share of the Issuer's common stock  reported on The Nasdaq Capital Market on October 1, 2018. There have been no other changes to the terms of the Relevant Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option was originally granted to the Reporting Person on July 31, 2018. This option vests over four (4) years of service following July 31, 2018, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and in thirty-six (36) equal monthly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":0.568,"expiration_date":"2028-07-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-18-026060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667584/000089924318026060/doc4.xml","form_type":"4"}},{"id":3798804,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":158106,"kind":"person","name":"Kelley Lynne E","position":1,"cik":"0001667584","reported_name":"Kelley Lynne E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-03T17:03:52.000Z","date":"2018-10-01","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") that became effective on October 1, 2018. Pursuant to the Option Repricing, the exercise price of each \"Relevant Option\" (any stock option awarded by the Issuer under it 2012 Equity Incentive Plan or 2013 Equity Incentive Plan with an exercise price greater than $ 0.75628 per share held by current service providers other than the non-employee members of the Issuer's board of directors) has been amended to reduce such exercise price to $0.568, which was the closing price of a share of the Issuer's common stock  reported on The Nasdaq Capital Market on October 1, 2018. There have been no other changes to the terms of the Relevant Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option was originally granted to the Reporting Person on July 31, 2018. This option vests over four (4) years of service following July 31, 2018, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and in thirty-six (36) equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":2.21,"expiration_date":"2028-07-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-18-026060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667584/000089924318026060/doc4.xml","form_type":"4"}},{"id":3856899,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":158106,"kind":"person","name":"Kelley Lynne E","position":1,"cik":"0001667584","reported_name":"Kelley Lynne E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-08-01T16:36:48.000Z","date":"2018-07-31","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over four (4) years of service following August 6, 2018, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and the balance vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":2.21,"expiration_date":"2028-07-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-18-020985","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667584/000089924318020985/doc4.xml","form_type":"4"}},{"id":4076415,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":158106,"kind":"person","name":"Kelley Lynne E","position":1,"cik":"0001667584","reported_name":"Kelley Lynne E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-05T18:31:35.000Z","date":"2018-02-02","kind":"grant","acquired":true,"shares":102192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares vest monthly over four years subject to the reporting person's continuous service with the issuer as of the applicable vesting date."}],"balance_after":102192,"derivative":{"exercise_price":2.62,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":102192},"source":{"system":"sec-edgar","filing":"0001209191-18-007645","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667584/000120919118007645/doc4.xml","form_type":"4"}},{"id":4486653,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":158106,"kind":"person","name":"Kelley Lynne E","position":1,"cik":"0001667584","reported_name":"Kelley Lynne E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-19T17:19:45.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares vest monthly over four years subject to the reporting person's continuous service with the issuer as of the applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":2.74,"expiration_date":"2027-01-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-17-004594","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667584/000120919117004594/doc4.xml","form_type":"4"}}]}